The landscape of diabetes management is dynamically shifting with the advent of GLP-1 agonists. These innovative medications, which mimic the actions of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), offer promising therapeutic benefits for individuals with type 2 diabetes. By {stimulatinginsulin secretion, GLP-1 agonists eff